Hormone replacement therapy and breast cancer risk

Annals of the New York Academy of Sciences

Volumn 900, Issue , 2000, Pages 422-428

  Koukoulis, George N ^a  

^a Endocrine Section   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; GESTAGEN;

ADULT; BREAST CANCER; CANCER RISK; CONFERENCE PAPER; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; OSTEOPOROSIS; POSTMENOPAUSE;

EID: 0034071140     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2000.tb06256.x     Document Type: Conference Paper

References (44)

1. 1. QUIGLEY, M.E.T. et al. 1987. Estrogen therapy arrests bone loss in elderly women. Am. J. Obstet. Gynecol. 156: 1516-1523.
2. 2. GRODSTEIN, F. & M.J. STAMPFER. 1995. The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women. Prog. Cardiovasc. Dis. 38: 199-210.
3. 3. GRODSTEIN, F. et al. 1998. Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann. Intern. Med. 128: 705-712.
4. 4. GALLE, E.E. et al. 1995. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J. Natl. Cancer. Inst. 87: 517-523.
5. 5. Consensus on Menopause of the European Menopause Society. 1996. Human Reprod. 11: 976-979.
6. 6. MCKAY HART, D. 1997. Current attitudes to hormone replacement therapy. Gynecol. Endocrinol. 11(Suppl 1):9-12.
7. 7. WINGO, P.A. et al. 1995. Cancer statistics. CA. Cancer. J. Clin. 45: 8-30.
8. 8. Consensus on Menopause of the European Menopause Society. 1996. Human Reprod. 11: 976-979.
9. 9. Annual Cancer Statistics Review. 1987. Bethesda, MD, National Institutes of Health, III-36: NIH publication 88-2789.
10. 10. CUTLER, S.Y. & J.L. YOUNG. 1975. Third National Cancer survey: incidence data. Washington, DC: National Cancer Institute monograph, vol 41.
11. 11. KUBISTA, E. 1997. Current standards of breast cancer treatment in Europe. Gynecol. Endocrinol. 11(Suppl 1): 23-28.
12. 12. BERNSTEIN, L. & R.K. Ross. 1993. Endogenous hormones and breast cancer risk. Epidemiol. Rev. 15: 48-65.
13. 13. JAMMES, V.H.T. & M.J. REED. 1980. Steroid hormones and human cancer. Prog. Cancer Res. Ther. 14: 471-487.
14. 14. WYSOWSKI, D.K. et al. 1987. Sex hormone levels in serum in relation to the development of breast cancer. Am. J. Epidemiol. 125: 791-799.
15. 15. GARLAND, C.F. et al. 1992. Sex hormones and postmenopausal breast cancer: a prospective study in an adult community. Am. J. Epidemiol. 135: 1220-1230.
16. 16. FEINLEIB, M. 1968. Breast cancer and artificial menopause: a cohort study. J. Natl. Cancer Inst. 41: 315-329.
17. 17. TRETLI, S. 1989. Height and weight in relation to breast cancer morbidity and mortality: a prospective study of 570,000 women in Norway. Int. J. Cancer 44: 23-30.
18. 18. COLDITZ, G.A. et al. 1995. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N. Engl. J. Med. 332: 1589-1593.
19. 19. EWERTZ, M. 1988. Influence of non-contraceptive exogenous and endogenous sex hormones on breast cancer risk in Denmark. Int. J. Cancer 42: 832-838.
20. 20. The writing group for the PEPI trial. 1995. Effects of estrogen orestrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA 273: 199-208.
21. 21. ANTURES, C.M.F. et al. 1979. Endometrial cancer and estrogen use: report of a large case-control study. N. Engl. J. Med. 300: 9-13.
22. 22. LOBO, R.A. 1992. The role of progestins in hormone replacement therapy. Am. J. Obstet. Gynecol. 166: 1997-2004.
23. 23. ARMSTRONG, B.K. 1988. Oestrogen therapy after the menopause - boon or bane? Med. J. Aust. 148: 213-214.
24. 24. STEINBERG, K.K. et al. 1991. A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer. J. Am. Med. Assoc. 265: 1985-1990.
25. 25. GRADY, O. et al. Hormone replacement therapy to prevent disease and prolong life in pestmenopausal women. Ann. Intern. Med. 117: 1016-1041.
26. 26. SILLERO-ARENAS, M. et al. 1992. Menopausal hormone replacement therapy and breast cancer: a meta-analysis. Obstet. Gynecol. 79: 286-294.
27. 27. COLDITZ, G.A. et al. 1993 Hormone replacement therapy and risk of breast cancer: results from epidemiological studies. Am. J. Obstet. Gynecol. 168: 1473-1480.
28. 28. MATHEWS, K.A. et al. 1989. Behavioral antecendents and consequences of the menopause. In The Menopause: Biological and Clinical Consequences of Ovarian Failure: Evolution and Management. S.G. Korenman, Ed. :1-10. Nada, CA. Serono Symposia.
29. 29. HULKA, B.S. 1990. Hormone replacement therapy and the risk of breast cancer. CA. Cancer J. Clin. 40: 289-296.
30. 30. DUPONT, W.D. & D.L. PAGE. 1991. Menopausal estrogen replacement therapy and breast cancer. Arch. Intern. Med. 151: 67-72.
31. 31. COLDITZ, GA. 1990. A prospective assessment of moderate alcohol intake and major chronic diseases. Ann. Epidemiol. 1: 167-177.
32. 32. BERGKVIST, L. et al. 1989. Prognosis after breast cancer diagnosis in women exposed to estrogen and estrogen-progestin replacement therapy. Am. J. Epidemiol. 130: 221-228.
33. 33. HENDERSON, B.E. et al. 1991. Decreased mortality in users of estrogen replacement Arch. Intern. Med. 151: 75-78.
34. 34. GRODSTEIN, F. 1997. Postmenopausal hormone therapy and mortality. N. Engl. J. Med. 336: 1769-1775.
35. 35. BEGKVIST, L. et al. 1989. The risk of breast cancer after estrogen and estrogen-progestin replacement. N. Engl. J. Med. 321: 293-297.
36. 36. BRINTON, L.A. et al. 1986. Menopausal estrogen and breast cancer risk: an expanded case-control study. Br. J. Cancer 54: 825-832.
37. 37. KENEMANS, P. & F. SCHEELE. 1997. Hormone replacement therapy in patients at high risk of developing breast cancer: the use of a combined risk model. Gynecol. Endocrinol. 11(Suppl 1): 17-22.
38. 38. ROSNER, D & W. LANE. 1986. Oral contraceptive use has no adverse effect on the prognosis of breast cancer. Cancer 57: 591-596.
39. 39. DISAIA, P.J. et al. 1996. Hormone replacement therapy in breast cancer survivors: a cohort study. Am. J. Obstet. Gynecol. 174: 1494-1498.
40. 40. CUMMINGS, S.R. et al. 1989. Lifetime risks of hip, Colls' or vertebral fracture and coronary heart disease among white postmenopausal women. Arch. Intern. Med. 149: 2445-2448.
41. 41. BRINTON, L.A. & C.S. SCHAIRER. 1997. Postmenopausal hormone-replacement therapy: time for a reappraisal? (editorial) N. Engl. J. Med. 336: 1821-1823.
42. 42. COL, N.F. et al. 1997. Patient-specific decisions about hormone replacement therapy in postmenopausal women. J. Am. Med. Assoc. 277: 1140-1147.
43. 43. COOPER, C. & E. BARRETT-CONNOR. 1996. The incidence of osteoporosis epidemiology. In Proceedings of the 1996 World Congress on Osteoporosis, Amsterdam, May 18-23. S. Papapoulos et al., Eds. :75-77. Elsevier. Amsterdam.
44. 44. MELTON, L.J. 1996. Global aspects of osteoporosis: epidemiology, in Proceedings of the 1996 World Congress on Osteoporosis, Amsterdam, May 18-23. S. Papapoulos et al., Eds. :79-86. Elsevier. Amsterdam.